Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Current Assets
QFR215385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
81,693.00
Year-over-Year Change
-7.34%
Date Range
10/1/2000 - 1/1/2025
Summary
This economic indicator tracks the current assets of U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides insight into the financial health and liquidity of a critical sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the total value of short-term assets held by pharmaceutical companies that can be converted to cash within one year. Economists use this metric to assess sector financial performance, investment potential, and overall economic resilience.
Methodology
Data is collected through comprehensive quarterly financial reporting by corporations in the pharmaceutical and medicine manufacturing sector.
Historical Context
This indicator is used by investors, policymakers, and financial analysts to evaluate sector-specific economic trends and potential market developments.
Key Facts
- Represents short-term financial resources in pharmaceutical corporations
- Provides quarterly snapshot of sector financial health
- Includes assets that can be quickly converted to cash
FAQs
Q: What does 'All Other Current Assets' include?
A: It includes short-term assets like accounts receivable, inventory, prepaid expenses, and other liquid financial resources not categorized in primary asset classes.
Q: Why are current assets important for pharmaceutical companies?
A: Current assets indicate a company's ability to fund operations, invest in research, and manage short-term financial obligations.
Q: How frequently is this data updated?
A: The data is updated quarterly, providing a consistent and timely view of the sector's financial condition.
Q: How do investors use this trend?
A: Investors analyze this trend to assess the financial stability and potential growth of pharmaceutical companies and the broader healthcare sector.
Q: What are the limitations of this data?
A: The data represents a snapshot in time and should be considered alongside other financial metrics for comprehensive analysis.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: All Retail Trade: Stockholders' Equity
QFR327RETUSNO
Quarterly Financial Report: U.S. Corporations: Wholesale Trade, Durable Goods: Cash Dividends Charged to Retained Earnings This Quarter
QFR120421USNO
Quarterly Financial Report: U.S. Corporations: Primary Metals: Inventories
QFR214PRIUSNO
Quarterly Financial Report: U.S. Corporations: All Professional and Technical Services, Except Legal Services: Short-Term Debt, Original Maturity of 1 Year or Less: Other Short-Term Loans, Including Commercial Paper
QFRD304PTSUSNO
Quarterly Financial Report: U.S. Corporations: Food: All Other Noncurrent Assets
QFRD222311USNO
Quarterly Financial Report: U.S. Corporations: Aerospace Products and Parts: Current Portion of Long-Term Debt, Due in 1 Year or Less: Other Long-Term Loans
QFRD313386USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Current Assets [QFR215385USNO], retrieved from FRED.
Last Checked: 8/1/2025